NCT01318642 2024-11-08Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the PancreasNantBioScience, Inc.Phase 2 Terminated10 enrolled 10 charts
NCT00819169 2024-08-20QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid TumorsNantCell, Inc.Phase 1/2 Terminated89 enrolled 20 charts